Table 3.
Reference (year) | Country | Study period (total) | No. of cases | Age at diagnosis (years)
|
FIGO stage
|
Years of follow-up (years)
|
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median/mean | (Range) | I | II–IV | Unstaged | Median/mean | (Range) | Women-years** | ||||
Hannibal et al. | Denmark | 1978–2002 (25 years) | 1042 | 50 | (15–96) | 886 (85%) | 145 (14%) | 11 (1%) | 15 | (0–36) | 16 183 |
Du Bois et al. (2013) | Germany | 1998–2008 (11 years) | 644 | 48 | (14–91) | 489 (76%) | 155 (24%) | – | 3.4* | NA | 2200 |
Park et al. (2011) | Korea | 1990–2010 (10 years) | 130 | 44 | (14–87) | 108 (83%) | 22 (17%) | – | 4.5 | (0.4–20) | 753 |
Quddus et al. (2011) | USA | 1991–2005 (15 years) | 188 | NA | NA | 171 (91%) | 17 (9%) | – | 5.6 | (0.6–22) | 1058 |
Shih et al. (2011) | USA | 1979–2008 (30 years) | 196 | 43* | (15–94) | 133 (68%) | 63 (32%) | – | 3.7* | (0–23) | 725 |
Uzan et al. (2011) | France | 1969–2006 (38 years) | 154 | 36 | (14–74) | 0 (0%) | 168 (100%) | – | 4.4 | (1–36) | 643 |
Kane et al. (2009) | France | 1973–2006 (34 years) | 168 | 36 | (14–77) | 41 (25%) | 127 (75%) | – | 4.8 | (0.1–36) | 760 |
Akeseon et al. (2008) | Sweden | 1993–2004 (12 years) | 219 | 55* | (16–90) | 197 (82%) | 22 (10%) | – | 7.7* | (2–13) | 1687 |
De laco et al. (2008) | Italy | 1985–2006 (22 years) | 102 | 46* | (14–85) | 72 (71%) | 30 (29%) | – | 5.0* | (0.3–20) | 514 |
Ren et al. (2008) | China | 2001–2007 (7 years) | 101 | 40* | (14–80) | 66 (65%) | 35 (35%) | – | 3.3* | (0.7–7) | 337 |
Cusido et al. (2007) | Spain | 1990–1997 (8 years) | 208 | 46* | NA | 177 (85%) | 21 (10%) | 10 (5%) | 7.3* | NA | 1525 |
Longacre et al. (2005) | USA | 1958–1998 (41 years) | 276 | 51 | (12–89) | 163 (59%) | 113 (41%) | – | 9.2 | (0.7–48) | 2500 |
Prat and Nictolis (2002) | Spain | 1980–1998 (19 years) | 137 | 39 | (14–84) | 92 (67%) | 45 (33%) | – | 7.2 | (1–18) | 762 |
Zanetta et al. (2001) | Italy | 1982–1997 (16 years) | 205 | 39* | NA | 171 (83%) | 34 (17%) | – | 5.8* | (1–15) | 1155 |
Rota et al. (1999) | Italy | 1982–1996 (15 years) | 188 | 46* | (16–74) | 125 (66%) | 18 (10%) | 45 (24%) | 6.6* | (0.8–14) | 1238 |
Barnhill et al. (1995) | USA | 1983–1992 10 years) | 146 | 44 | (19–79) | 146 (100%) | 0 (0%) | – | 3.5 | (0.8–14) | 516 |
Kaern et al. (1993) | Norway | 1970–1982 (13 years) | 174 | 53* | (15–83) | 148 (85%) | 26 (15%) | – | 12.4* | (0.4–21) | 2161 |
Trope et al. (1993) | Norway | 1970–1988 (19 years) | 114 | 48* | (15–81) | 109 (96%) | 5 (4%) | – | 12.3* | (0.3–21) | 1397 |
Leake et al. (1992) | USA | 1979–1984 (6 years) | 200 | 34 | (6–98) | 135 (67.5%) | 65 (32.5%) | – | 10 | (4–27) | 2240 |
Abbreviations: International Federation of Gynecology and Obstetrics (FIGO); number (No.); not available (NA). If a study population is published several times, only data from the newest paper is presented in the table.
Also based on women with other histologic subtypes of borderline ovarian tumors.
Calculated based on the number of women included in the study (N) and the number of median/mean years of follow-up (M) (N × M = women-years of follow-up).